 Infants at high-risk of serious Respiratory Syncytial Virus RSV illness infants born 35 weeks of gestation and infants 24 months with Bronchopulmonary Dysplasia BPD or Congenital Heart Disease CHD who received immunoprophylaxis during the RSV season defined as October 2014 through April 2015 in routine clinical settings in the Russian Federation. 